From 2013 to 2023, the dosage market size value per capita for Penicillins and Streptomycins in the US experienced fluctuations. In 2023, the value stood at $12.93. Between 2021 and 2023, the market size underwent a slight increase of 0.57%. Over the last five years, the compound annual growth rate (CAGR) averaged 0.28%, indicating gradual growth despite some volatility.
Future trends to monitor include advancements in biotechnology potentially affecting these antibiotics, regulatory changes impacting production and pricing, and evolving bacterial resistance patterns, which may drive demand fluctuations in the dosage market.
